Pruritus Therapeutics Global Market Report 2024

Description

Pruritus therapeutics pertains to the treatments employed to alleviate an uncomfortable skin sensation prompting a desire to scratch. This approach is commonly applied to alleviate swelling and inflammation in moderate-to-severe inflammatory skin conditions.

The primary product categories of pruritus therapeutics encompass corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and others. Corticosteroids denote synthetic anti-inflammatory medications utilized to address itching and inflammation resulting from pruritus. These medications can be administered through various routes, including oral, parenteral, and topical, aiding in the treatment of diverse disease types such as atopic dermatitis, allergic contact dermatitis, urticaria, cutaneous T-cell, among others. They find application in hospitals, clinics, and other medical settings.

The pruritus therapeutics research market report is one of a series of new reports from The Business Research Company that provides pruritus therapeutics market statistics, including pruritus therapeutics industry global market size, regional shares, competitors with a pruritus therapeutics market share, detailed pruritus therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pruritus therapeutics industry. This pruritus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pruritus therapeutics market size has grown strongly in recent years. It will grow from $11.39 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The increase observed during the historical period can be ascribed to a rise in the incidence of pruritus, a variety of causes and conditions, the growing aging population, and a heightened focus on improving patient quality of life.

The pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The expansion projected for the forecast period can be linked to the broader understanding of pruritus pathophysiology, advancements in drug formulations and delivery methods, a spotlight on personalized medicine, a surge in dermatological research and development, heightened awareness and diagnosis rates, and an increasing interest in botanical and herbal remedies. Noteworthy trends anticipated during the forecast period encompass the development of itch-specific receptor agonists and antagonists, a market emphasis on personalized therapeutic approaches, the integration of technology in itch monitoring and management, and collaborative efforts for cross-disciplinary research.

The pruritus therapeutics market is anticipated to witness growth due to the increasing incidence of dermatological disorders. Dermatological disorders encompass a range of conditions affecting the skin, hair, nails, and mucous membranes, including acne, eczema, skin cancer, and fungal infections. The use of pruritus treatments is often determined by the underlying cause of itching, involving topical treatments, emollients, immunosuppressant medications, and specific itching medications. A report by the American Cancer Society Inc. revealed a 5.8% increase in skin cancer cases from 2020 to 2021, reaching 108,480 cases. This surge in dermatological disorders is a driving force behind the growth of the pruritus therapeutics market.

The global increase in the geriatric population is expected to contribute to the expansion of the ocular implant market. The geriatric population, comprising individuals aged 65 and older, is more susceptible to pruritus due to various factors associated with aging. According to the World Health Organization, the global population of individuals aged 60 and above is projected to reach 1.4 billion by 2022, compared to 1 billion in 2020. The aging population's specific needs make pruritus therapeutics crucial in addressing itching concerns. The rise in the geriatric population worldwide is poised to drive the growth of the pruritus therapeutics market. Notably, Ipsen, a France-based biopharmaceutical company, collaborated with Medison Pharma in November 2023 to develop an innovative pruritus treatment, Bylvay, for patients aged 6 months or older with Progressive Familial Intrahepatic Cholestasis (PFIC).

A prominent trend in the pruritus therapeutics market is product innovation, with major companies focusing on developing novel treatments to strengthen their market position. For instance, in August 2021, Fresenius Medical Care AG & Co., a Germany-based provider for people with kidney illnesses, launched KORSUVA (difelikefalin) for reducing pruritus related to chronic kidney dysfunction in adults undergoing hemodialysis. This therapeutic injectable drug, approved by the FDA, is a first-in-class kappa opioid receptor (KOR) targeting the outer neurological system. Product innovation remains a key strategy for companies aiming to enhance the safety and effectiveness of pruritus treatments.

Leading companies in the pruritus therapeutics market are concentrating on the development of oral solutions for managing cholestatic pruritus in patients with Alagille syndrome (ALGS) aged one year and older. An oral solution for cholestatic pruritus is a liquid medication designed to alleviate itching associated with liver conditions. In September 2021, Mirum Pharmaceuticals, Inc., a US-based biotechnology company, received FDA approval for LIVMARLI (maralixibat) oral solution to manage cholestatic pruritus in individuals aged one year and older with ALGS. The company's Mirum Access Plus (MAP) program provides access to LIVMARLI, offering support services, insurance coverage, and financial assistance through dedicated coordinators.

In March 2023, Ipsen, the France-based biopharmaceutical company, acquired Albireo Pharma, Inc., a US-based clinical-stage biopharmaceutical company. This strategic acquisition aims to expand Ipsen's portfolio by incorporating promising medicines for pediatric and adult uncommon cholestatic liver disorders. Albireo Pharma, Inc., specializes in oral drugs, including the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC). The acquisition enriches Ipsen's capabilities with unique pipeline potential and scientific and commercial expertise.

Major companies operating in the pruritus therapeutics market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Eli Lilly and Company, Amgen Inc. , Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Brunswick Corporation, Galderma Laboratories LP, Cipla Limited, Vifor Pharma Ltd., Carl Zeiss Meditec AG, LEO Pharma AS, Mirum Pharmaceuticals Inc., Cara Therapeutics Inc., GlaxoSmithKline PLC, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

North America was the largest region in the pruritus treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pruritus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pruritus therapeutics market consists of revenues earned by entities by providing topical therapy, phototherapy, and systemic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The pruritus therapeutics market also include sales of hydroxyzine, benadryl, banophen, diphedryl, and allermax. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pruritus Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pruritus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pruritus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pruritus therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressants; Calcineurin Inhibitors; Other Products
2) By Route of Administration: Oral; Parenteral; Topical
3) By Disease Type: Atopic Dermatitis; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types
4) By End-User: Hospitals; Clinics; Other End Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13827

1. Executive Summary

2. Pruritus Therapeutics Market Characteristics

3. Pruritus Therapeutics Market Trends And Strategies

4. Pruritus Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pruritus Therapeutics Market Size and Growth

5.1. Global Pruritus Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pruritus Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pruritus Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pruritus Therapeutics Market Segmentation

6.1. Global Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Other Products
6.2. Global Pruritus Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Topical
6.3. Global Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Cutaneous T-Cell
Other Disease Types
6.4. Global Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Other End Users

7. Pruritus Therapeutics Market Regional And Country Analysis

7.1. Global Pruritus Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pruritus Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pruritus Therapeutics Market

8.1. Asia-Pacific Pruritus Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pruritus Therapeutics Market

9.1. China Pruritus Therapeutics Market Overview
9.2. China Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pruritus Therapeutics Market

10.1. India Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pruritus Therapeutics Market

11.1. Japan Pruritus Therapeutics Market Overview
11.2. Japan Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pruritus Therapeutics Market

12.1. Australia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pruritus Therapeutics Market

13.1. Indonesia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pruritus Therapeutics Market

14.1. South Korea Pruritus Therapeutics Market Overview
14.2. South Korea Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pruritus Therapeutics Market

15.1. Western Europe Pruritus Therapeutics Market Overview
15.2. Western Europe Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pruritus Therapeutics Market

16.1. UK Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pruritus Therapeutics Market

17.1. Germany Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pruritus Therapeutics Market

18.1. France Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pruritus Therapeutics Market

19.1. Italy Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pruritus Therapeutics Market

20.1. Spain Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pruritus Therapeutics Market

21.1. Eastern Europe Pruritus Therapeutics Market Overview
21.2. Eastern Europe Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pruritus Therapeutics Market

22.1. Russia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pruritus Therapeutics Market

23.1. North America Pruritus Therapeutics Market Overview
23.2. North America Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pruritus Therapeutics Market

24.1. USA Pruritus Therapeutics Market Overview
24.2. USA Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pruritus Therapeutics Market

25.1. Canada Pruritus Therapeutics Market Overview
25.2. Canada Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pruritus Therapeutics Market

26.1. South America Pruritus Therapeutics Market Overview
26.2. South America Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pruritus Therapeutics Market

27.1. Brazil Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pruritus Therapeutics Market

28.1. Middle East Pruritus Therapeutics Market Overview
28.2. Middle East Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pruritus Therapeutics Market

29.1. Africa Pruritus Therapeutics Market Overview
29.2. Africa Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pruritus Therapeutics Market Competitive Landscape And Company Profiles

30.1. Pruritus Therapeutics Market Competitive Landscape
30.2. Pruritus Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi S.A.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bristol-Myers Squibb Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pruritus Therapeutics Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Eli Lilly and Company
31.3. Amgen Inc.
31.4. Regeneron Pharmaceuticals Inc.
31.5. Astellas Pharma Inc.
31.6. Bausch Health Companies Inc.
31.7. Brunswick Corporation
31.8. Galderma Laboratories LP
31.9. Cipla Limited
31.10. Vifor Pharma Ltd.
31.11. Carl Zeiss Meditec AG
31.12. LEO Pharma AS
31.13. Mirum Pharmaceuticals Inc.
31.14. Cara Therapeutics Inc.
31.15. GlaxoSmithKline Plc

32. Global Pruritus Therapeutics Market Competitive Benchmarking

33. Global Pruritus Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pruritus Therapeutics Market

35. Pruritus Therapeutics Market Future Outlook and Potential Analysis

35.1 Pruritus Therapeutics Market In 2028 - Countries Offering Most New Opportunities
35.2 Pruritus Therapeutics Market In 2028 - Segments Offering Most New Opportunities
35.3 Pruritus Therapeutics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer